Spark Investment Management’s Coherus Oncology CHRS Stock Holding History

Spark Investment Management’s Portfolio CHRS Stock Details CHRS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$24.9K	Buy	+17,800	New	+$29.1K	0.05%	68
2017 Q2	–	Sell	-124,900	Closed	-$2.64M	–	782
2017 Q1	$2.64M	Buy	124,900 +104,300	+506%	+$2.57M	0.17%	200
2016 Q4	$579K	Sell	20,600 -64,300	-76%	-$1.8M	0.05%	453
2016 Q3	$2.27M	Sell	84,900 -100,500	-54%	-$2.74M	0.18%	168
2016 Q2	$3.13M	Buy	+185,400	New	+$3.48M	0.29%	102
2015 Q3	–	Sell	-9,367	Closed	-$270K	–	681
2015 Q2	$270K	Buy	+9,367	New	+$237K	0.04%	464

Other funds holding CHRS

TGY2IT

Timothy G. Youngquist 2020 Irrevocable Trust Fort Myers, Florida $530M AUM 95.29% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Samsara BioCapital Palo Alto, California $1.22B AUM 242.83% 1-Year Est. Return

KKRC

Kohlberg Kravis Roberts & Co New York $5.71B AUM 72.37% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

CM Management Gulf Breeze, Florida $157M AUM 60.08% 1-Year Est. Return

CWG

C WorldWide Group Copenhagen, Denmark $4.15B AUM 13.14% 1-Year Est. Return

Spark Investment Management's CHRS Position: Q2 2026 in Review

Spark Investment Management opened a new position in Coherus Oncology (CHRS) in Q2 2026: 17,800 shares worth $24.9K. The stake represents 0.05% of the portfolio and ranks #68 among its holdings. This is a return to the name: Spark Investment Management previously reported a position in CHRS as recently as Q1 2017.

Spark Investment Management first reported a position in CHRS in Q2 2015 and has held it in 6 quarters since. The position peaked at $3.13M in Q2 2016. 146 funds tracked by Wall St. Rank hold CHRS as of Q2 2026.

Spark Investment Management held 17,800 shares of Coherus Oncology worth $24.9K as of Q2 2026.
Coherus Oncology was a new Spark Investment Management position in Q2 2026.
Coherus Oncology made up 0.05% of Spark Investment Management's portfolio in Q2 2026, its #68 holding.
Spark Investment Management first reported a position in Coherus Oncology in Q2 2015 and has held it in 6 quarters since.
Spark Investment Management's Coherus Oncology position peaked at $3.13M in Q2 2016.
146 funds tracked by Wall St. Rank held Coherus Oncology as of Q2 2026.

Based on Spark Investment Management's 13F filing for Q2 2026, filed 10 Aug 2026.